Alyeska Investment Group’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Alyeska Investment Group’s Portfolio SNCE Stock Details SNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-88,319	Closed	-$472K	–	658
2023 Q4	$472K	Hold	88,319	–	–	﹤0.01%	437
2023 Q3	$707K	Hold	88,319	–	–	﹤0.01%	435
2023 Q2	$375K	Hold	88,319	–	–	﹤0.01%	508
2023 Q1	$497K	Buy	88,319 +15,000	+20%	+$114K	﹤0.01%	415
2022 Q4	$609K	Buy	73,319 +20,869	+40%	+$408K	0.01%	366
2022 Q3	$1.69M	Buy	52,450 +20,886	+66%	+$774K	0.02%	327
2022 Q2	$1.27M	Sell	31,564 -5,000	-14%	-$365K	0.01%	449
2022 Q1	$3.91M	Sell	36,564 -6,218	-15%	-$974K	0.04%	330
2021 Q4	$9.78M	Buy	42,782 +18,417	+76%	+$4.09M	0.11%	200
2021 Q3	$4.78M	Buy	24,365 +23,074	+1,787%	+$4.6M	0.06%	342
2021 Q2	$258K	Buy	+1,291	New	+$262K	﹤0.01%	677

Alyeska Investment Group's SNCE Position: Q1 2024 in Review

Alyeska Investment Group sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q1 2024, closing a stake of 88,319 shares — an estimated $472K sold.

Alyeska Investment Group first reported a position in SNCE in Q2 2021 and held it in 11 quarters. The position peaked at $9.78M in Q4 2021. 0 funds tracked by Wall St. Rank hold SNCE as of Q1 2024.

Alyeska Investment Group reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Alyeska Investment Group sold 88,319 Science 37 Holdings, Inc. Common Stock shares in Q1 2024, an estimated $472K.
Alyeska Investment Group first reported a position in Science 37 Holdings, Inc. Common Stock in Q2 2021 and held it in 11 quarters.
Alyeska Investment Group's Science 37 Holdings, Inc. Common Stock position peaked at $9.78M in Q4 2021.
0 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q1 2024.

Based on Alyeska Investment Group's 13F filing for Q1 2024, filed 15 May 2024.